CONFIRMING STATEMENT





This Statement confirms that the undersigned has authorized and

designated the Chief Executive Officer the Chief Financial Officer

or the Chief Operating Officer of Galectin Therapeutics Inc

(the Company) to execute and file on the undersigneds behalf

all Forms 3 4 and 5 (including any amendments thereto) that

the undersigned may be required to file with the U.S. Securities

and Exchange Commission as a result of the undersigned's ownership

of or transactions in securities of the Company  The authority of the

Chief Executive Officer the Chief Financial Officer or the Chief

Operating Officer of the Company under this Statement shall continue

until the undersigned is no longer required to file Forms 3 4 and 5

with regard to the undersigned's ownership of or transactions in

securities of the Company unless earlier revoked in writing  The

undersigned acknowledges that the Chief Executive Officer the

Chief Financial Officer or the Chief Operating Officer of the

Company is not assuming any of the undersigneds responsibilities

to comply with Section 16 of the Securities Exchange Act of 1934







Dated as of  July 12 2013

/s/ Steven Prelack

Signature







Steven Prelack

Print Name